[Beta 3 adrenergic receptor agonist].
Sakura
Hiroshi
H
Diabetes Center, Tokyo Women's Medical University.
D000085:Acetates; D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000818:Animals; D019440:Anti-Obesity Agents / Q000008:administration & dosage; D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007211:Indoles / Q000008:administration & dosage; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D000078790:Insulin Secretion; D022702:Receptors, Adrenergic, beta-3 / Q000737:chemistry / Q000502:physiology
C418363:((3-((2R)-(((2R)-3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-1H-indol-7-yloxy)acetic acid; D000085:Acetates; D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists; D019440:Anti-Obesity Agents; D007004:Hypoglycemic Agents; D007211:Indoles; D007328:Insulin; D022702:Receptors, Adrenergic, beta-3